Let’s start up with the current stock price of Verve Therapeutics Inc. (VERV), which is $36.34 to be very precise. The Stock rose vividly during the last session to $36.86 after opening rate of $35.09 while the lowest price it went was recorded $34.1363 before closing at $35.58.Recently in News on September 22, 2022, Verve Therapeutics to Participate in Upcoming Investor Conferences. Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced that management will participate in the following upcoming investor conferences:. You can read further details here
Verve Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $43.00 on 08/25/22, with the lowest value was $10.70 for the same time period, recorded on 06/16/22.
Verve Therapeutics Inc. (VERV) full year performance was -22.71%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Verve Therapeutics Inc. shares are logging -35.32% during the 52-week period from high price, and 239.63% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $10.70 and $56.18.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 904763 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Verve Therapeutics Inc. (VERV) recorded performance in the market was -1.44%, having the revenues showcasing 124.60% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 2.47B, as it employees total of 113 workers.
Verve Therapeutics Inc. (VERV) in the eye of market guru’s
During the last month, 0 analysts gave the Verve Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 24.27, with a change in the price was noted +21.42. In a similar fashion, Verve Therapeutics Inc. posted a movement of +143.57% for the period of last 100 days, recording 1,029,373 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for VERV is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Verve Therapeutics Inc. (VERV): Stocks Technical analysis and Trends
Raw Stochastic average of Verve Therapeutics Inc. in the period of last 50 days is set at 68.18%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 24.86%. In the last 20 days, the company’s Stochastic %K was 23.12% and its Stochastic %D was recorded 27.01%.
If we look into the earlier routines of Verve Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -1.44%. Additionally, trading for the stock in the period of the last six months notably improved by 61.37%, alongside a downfall of -22.71% for the period of the last 12 months. The shares increased approximately by -12.41% in the 7-day charts and went down by -1.17% in the period of the last 30 days. Common stock shares were driven by 124.60% during last recorded quarter.